Bessemer Group Inc. Has $51,000 Holdings in Privia Health Group, Inc. (NASDAQ:PRVA)

Bessemer Group Inc. boosted its position in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 2,393.4% during the first quarter, HoldingsChannel reports. The institutional investor owned 2,269 shares of the company’s stock after purchasing an additional 2,178 shares during the period. Bessemer Group Inc.’s holdings in Privia Health Group were worth $51,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of the company. Quadrant Capital Group LLC grew its stake in Privia Health Group by 11.8% during the fourth quarter. Quadrant Capital Group LLC now owns 4,855 shares of the company’s stock worth $95,000 after buying an additional 511 shares in the last quarter. Park Avenue Securities LLC grew its stake in Privia Health Group by 3.6% during the first quarter. Park Avenue Securities LLC now owns 15,229 shares of the company’s stock worth $342,000 after buying an additional 532 shares in the last quarter. PNC Financial Services Group Inc. grew its stake in Privia Health Group by 8.0% during the fourth quarter. PNC Financial Services Group Inc. now owns 7,169 shares of the company’s stock worth $140,000 after buying an additional 533 shares in the last quarter. Summit Investment Advisors Inc. grew its stake in Privia Health Group by 6.8% during the fourth quarter. Summit Investment Advisors Inc. now owns 10,673 shares of the company’s stock worth $209,000 after buying an additional 678 shares in the last quarter. Finally, Financial Management Professionals Inc. grew its stake in Privia Health Group by 28.7% during the first quarter. Financial Management Professionals Inc. now owns 3,383 shares of the company’s stock worth $76,000 after buying an additional 754 shares in the last quarter. 94.48% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

PRVA has been the topic of a number of analyst reports. JMP Securities reiterated a “market outperform” rating and set a $29.00 price objective on shares of Privia Health Group in a research note on Monday, April 28th. Barclays increased their price objective on shares of Privia Health Group from $23.00 to $24.00 and gave the stock an “equal weight” rating in a research note on Tuesday, May 27th. Robert W. Baird increased their price objective on shares of Privia Health Group from $24.00 to $26.00 and gave the stock an “outperform” rating in a research note on Tuesday, April 15th. Needham & Company LLC reiterated a “buy” rating and set a $30.00 price objective on shares of Privia Health Group in a research note on Thursday, April 10th. Finally, JPMorgan Chase & Co. increased their target price on shares of Privia Health Group from $29.00 to $32.00 and gave the stock an “overweight” rating in a report on Wednesday, May 28th. One investment analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average price target of $27.77.

Insider Transactions at Privia Health Group

In related news, CEO Parth Mehrotra sold 15,100 shares of the firm’s stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $23.33, for a total value of $352,283.00. Following the completion of the transaction, the chief executive officer owned 454,281 shares in the company, valued at $10,598,375.73. This trade represents a 3.22% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Matthew Shawn Morris sold 10,309 shares of the firm’s stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $23.33, for a total transaction of $240,508.97. Following the completion of the transaction, the director owned 59,792 shares of the company’s stock, valued at approximately $1,394,947.36. This trade represents a 14.71% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 45,949 shares of company stock valued at $1,100,368. 10.70% of the stock is currently owned by insiders.

Privia Health Group Trading Up 0.9%

PRVA stock opened at $22.11 on Friday. The stock has a market capitalization of $2.70 billion, a P/E ratio of 184.27, a price-to-earnings-growth ratio of 3.51 and a beta of 0.82. Privia Health Group, Inc. has a 12 month low of $16.47 and a 12 month high of $26.09. The firm has a 50-day moving average price of $23.10 and a 200-day moving average price of $22.88.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.